GLP-1 weight loss, side effects linked to genetic variations Weight-loss responses to GLP-1 obesity drugs, and risks of side effects, may be linked to genetic variants, according to a study conducted by DNA-testing service 23AndMe.

GLP-1 weight loss, side effects linked to genetic variations reut.rs/4snBdpF

How is this related to finance?

Microsoft caught in the perfect storm of AI disruption and EU tech independence 🌪️
techcrunch.com/2026/04/10/f...

I also noticed this one from @nationalbanken.dk. bsky.app/profile/nati...

Adobe is growing double digit. Single digit forward P/E. Cash less debt is zero. I'm loading up the truck 🪏 ServiceNow and others might still have room to fall. We might not bounce, until all of them are trading at rock bottom prices and AI disruption fears do not materialize.

"A valuation discount Europe enjoyed is vanishing fast, with US stocks experiencing a sharp de-rating of their own that’s closing the gap."

-BBG

I am currently using Claude Code. How is this better?

Someone call an ambulance 🚑 #IGV #QQQ

I hope the new Adobe CEO will not be given a financial incentive to do a short term boost of the stock price by for example paying a dividend. The dividend fans can stick to their dividend paying stocks. Adobe is not the only software stock without a fan base these days.
#SaaSocalypse

As a new Adobe shareholder I hope they do not start paying a dividend. Full throttle on R&D and buybacks please. I hope it stays undervalued for many years, so they can buy back half of the shares or more.

Why obesity drugs work better for some people: these genes hold clues Study of almost 28,000 people also identifies genetic variants that raise the risk of gastrointestinal side effects from GLP-1 medications.

Scientists have identified a set of genetic variants that could help to explain why responses to obesity drugs vary markedly from person to person

go.nature.com/4ccK07M

You need to add more gold to the crust... 🦧

Is that legal? Have they arrested anyone from LinkedIn/Microsoft? I use Brave. Not immune to this kind of profiling.

Does that mean bonuses will be reduced this year?

I only ever watched Barbarians at the Gate. I really enjoyed Flash Boys. Have fun with your purchases 😊📚

Tag eventuelt et kig på Lululemon. Har indtil videre vokset hurtigere i Kina end Nike.
www.midgardfinance.com/geo/china/#C...

Stacked bar chart of survey responses showing how worried US working adults are that their work could be automated within their lifetime, across survey waves from January 14, 2021 to January 7, 2026. The data source is the YouGov (2026). The chart is licensed CC BY to Our World in Data.

📊 Data update: Are Americans worried about AI taking their jobs?

As artificial intelligence advances rapidly, how are Americans’ attitudes about it changing? Are they becoming more concerned about automation, or less?

Done. You know you are popular, when people start impersonating you.

Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly Longer subscriptions offer lower monthly pricing, with people expected to save up to $1,200 a year on the injection and as much as $600 a year on the pill.

Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly

All of the above.

Walmart. More predictable.

Does anyone know, if it is significantly better than Claude Code? I like Anthropic, because it is the more socially responsible company. Google and OpenAI are evil.

So tired of winning 🏆🪖🛢️

Ever wondered how oil circles the globe? 🛢️

Babajide Omisade breaks down the complex pathways: www.voronoiapp.com/category/How-is-Oil-Tran...

Fin virksomhed. Vokser lidt langsomt. Andre bryggerier har bedre margener. Skål 🍻

Would he have an interest in saying that?

a woman speaking into a microphone with a sign that says attorney box ALT: a woman speaking into a microphone with a sign that says attorney box

Is the Dow still over 50,000? 🤡

Exclusive: Verily raises $300M, sheds Alphabet’s majority control Verily raises $300M, transitions from Alphabet control to independent company Verily Health. Series X Capital leads round with Alphabet, UCHealth & others participating.

⚡ Exclusive: Verily becomes 'independent company' with $300M raise
endpoints.news/verily-raise...

Weight-loss drugs linked to lower depression and anxiety risk, study GLP-1 weight-loss drugs with semaglutide were associated with a lower risk of depression, anxiety, substance use disorders, and self-harm, according to a new study.

GLP-1 weight-loss drugs with semaglutide were associated with a lower risk of depression, anxiety, substance use disorders, and self-harm, according to a new study.

Lilly reports encouraging trial results for its next-gen GLP-1 shot Patients taking the highest dose of retatrutide lost 16.8% of their body weight after 40 weeks, more than its current best-seller, tirzepatide....

Patients taking the highest dose of retatrutide lost 16.8% of their body weight after 40 weeks, more than its current best-seller, tirzepatide.
sherwood.news/markets/lilly-reports-en...